In a patient receiving ceftriaxone for meningitis who remains febrile and now has a Glasgow Coma Scale of 14/15, what are the differential diagnoses and their rationale?

Differential Diagnoses in a Febrile Meningitis Patient on Ceftriaxone with GCS 14/15

In a patient receiving ceftriaxone for meningitis who remains febrile with altered mental status (GCS 14/15), you must immediately consider: intracranial complications of meningitis (cerebrovascular events, hydrocephalus, subdural empyema), ceftriaxone-induced encephalopathy, treatment failure due to resistant organisms, or an alternative/concurrent infection.

Primary Differential Diagnoses and Rationale

1. Intracranial Complications of Bacterial Meningitis

This is the most critical consideration given the high frequency and mortality implications.

• Cerebrovascular complications occur frequently during bacterial meningitis and can cause neurological deterioration 1
• Half of adults with bacterial meningitis develop focal neurologic deficits during their clinical course 1
• Specific complications include:
  • Cerebral infarction/vasculitis (can occur despite adequate antibiotic levels) 2
  • Hydrocephalus (both obstructive and communicating)
  • Subdural empyema
  • Brain abscess
  • Intracerebral hemorrhage
  • Cerebral edema

Clinical approach: Obtain urgent cranial imaging (MRI preferred over CT for superior resolution, though CT is faster and more available) 1. The persistent fever with declining GCS mandates neuroimaging to exclude space-occupying lesions or vascular complications that may require neurosurgical intervention 1.

2. Ceftriaxone-Induced Encephalopathy

This is an underrecognized but reversible cause that must be considered, especially given the drug label warnings.

• Ceftriaxone can cause encephalopathy with disturbance of consciousness, confusion, lethargy, seizures, myoclonus, and nonconvulsive status epilepticus 3
• Risk factors include older age, renal insufficiency, and high drug levels 4, 5
• High ceftriaxone levels in blood and CSF are directly related to encephalopathy development 5
• Discontinuation leads to rapid improvement within 2-6 days 4, 5

Clinical approach: Consider EEG to look for triphasic waves suggestive of encephalopathy 4. If other causes are excluded and encephalopathy is suspected, discontinue ceftriaxone and observe for improvement within 48 hours 4.

3. Treatment Failure: Resistant or Inadequately Covered Organisms

Emergence of resistance can occur even during appropriate therapy.

• Ceftriaxone resistance can develop during treatment - a documented case showed S. pneumoniae developing increased MICs to third-generation cephalosporins through PBP2X mutation after 10 days of therapy, despite effective serum and CSF concentrations 2
• Atypical organisms not covered by ceftriaxone:
  • Listeria monocytogenes (requires ampicillin/amoxicillin, not covered by cephalosporins) 6
  • Mycoplasma pneumoniae (requires macrolides or doxycycline) 6
  • Fungal meningitis (requires antifungals)
  • Tuberculous meningitis (requires anti-TB therapy)

Clinical approach: Review initial CSF findings - lymphocytic predominance suggests Listeria or partially treated bacterial meningitis 7. Consider repeat lumbar puncture if clinically indicated, though routine repetition has limited yield 1. Broaden antimicrobial coverage empirically: add ampicillin for Listeria coverage in elderly/immunocompromised patients 8.

4. Concurrent or Alternative Infection

Nosocomial infections or other sources of fever must be excluded.

• Nosocomial meningitis/ventriculitis (if CNS devices present) 9
• Hospital-acquired pneumonia
• Catheter-related bloodstream infection
• Drug fever
• Non-infectious causes: pulmonary embolism, deep vein thrombosis

Clinical approach: Systematic search for alternative infection sources with blood cultures, chest imaging, and assessment of all invasive devices.

5. Seizures (Including Nonconvulsive Status Epilepticus)

Seizures can explain both fever and altered mental status in meningitis patients.

• Seizures are common complications during bacterial meningitis 1
• Nonconvulsive status epilepticus can present with altered consciousness without obvious motor manifestations 3

Clinical approach: Obtain urgent EEG, particularly if no other cause is identified 1.

Critical Pitfalls to Avoid

1. Do not assume adequate antibiotic coverage - even appropriate initial therapy can fail due to resistance emergence 2 or inadequate organism coverage 6

2. Do not delay neuroimaging - with GCS ≤14 (or drop of ≥2 points), patients should be transferred to critical care and imaging should be expedited 7

3. Do not overlook drug-induced encephalopathy - this reversible cause is frequently missed 4

4. Do not forget Listeria - cephalosporins do not cover this organism; add ampicillin empirically in elderly or immunocompromised patients 8

Immediate Management Algorithm

1. Stabilize and assess severity: GCS 14/15 warrants close monitoring; consider ICU transfer if further decline occurs 7

2. Obtain urgent neuroimaging (CT or MRI) to exclude intracranial complications 1

3. Perform targeted physical examination: Look for focal neurological signs, papilledema, signs of herniation, new rash, or seizure activity

4. Consider EEG if encephalopathy or subclinical seizures suspected 1, 4

5. Broaden antimicrobial coverage empirically:

   • Add ampicillin 2g IV every 4 hours for Listeria coverage (especially if age >50 or immunocompromised) 8
   • Consider aciclovir if viral encephalitis possible 8

6. Review initial CSF parameters and culture results - lymphocytic predominance, atypical presentation, or culture-negative meningitis should prompt consideration of alternative organisms 7, 6

7. If no clear cause identified and patient stable: Consider ceftriaxone-induced encephalopathy and trial of drug discontinuation with alternative antibiotic 4, 5